zimberelimab
Showing 26 - 34 of 34
Advanced NSCLC Trial in Spokane (Zimberelimab, Domvanalimab, Quemliclustat)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Zimberelimab
- +4 more
-
Spokane, WashingtonMedical Oncology Associates
Jan 5, 2023
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Advanced Solid Tumors Trial in United States (zimberelimab)
Active, not recruiting
- Advanced Solid Tumors
- zimberelimab
-
Riverside, California
- +10 more
Dec 6, 2022
Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non-small-cell Lung Cancer Trial in Worldwide
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- Zimberelimab
- +4 more
-
Dhaka, Bangladesh
- +139 more
Dec 8, 2022
Gastrointestinal Tract Malignancies Trial in Sarasota, Nashville (Zimberelimab, Domvanalimab, Fluorouracil)
Recruiting
- Gastrointestinal Tract Malignancies
- Zimberelimab
- +5 more
-
Phoenix, Arizona
- +26 more
Jan 20, 2023
Metastatic Urothelial Cancer Trial in France, United States (Sacituzumab Govitecan-hziy, Pembrolizumab, Cisplatin)
Recruiting
- Metastatic Urothelial Cancer
- Sacituzumab Govitecan-hziy
- +7 more
-
Tucson, Arizona
- +44 more
Jan 9, 2023
Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Magrolimab
- +6 more
-
Chandler, Arizona
- +59 more
Jan 20, 2023
Metastatic Colorectal Cancer Trial in Worldwide (etrumadenant, zimberelimab, mFOLFOX-6 regimen)
Recruiting
- Metastatic Colorectal Cancer
- etrumadenant
- +5 more
-
Birmingham, Alabama
- +62 more
Apr 1, 2022